← brief for 2026-10-31 · Slowing decline

Comparison of the Effectiveness and Safety of Allopurinol and Febuxostat Use in CKD Patients with Hyperuricemia: A Systematic Review

Article A Peer reviewed Meta-analysis or large trial

Key takeaways

This review looked at many studies to compare two drugs used to lower uric acid. It focused on people with kidney disease. The review found that both drugs are generally safe for these patients. This helps doctors choose the right treatment to protect the kidneys and heart.

Who did this work

Fiolita Etsa Aurora (Universitas 17 Agustus 1945 Jakarta) · Ida Paulina Sormin (Universitas 17 Agustus 1945 Jakarta)

Source

Article · OpenAlex, CKD works · 2026-10-30
https://doi.org/10.35451/jfm.v9i1.3890